GIA
IBB icon

GHP Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

GHP Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-46
Closed -$6.7K – 1008
2024
Q3 		$6.7K Buy
+46
New +$6.66K ﹤0.01% 772
2024
Q2 		– Sell
-145
Closed -$19.9K – 984
2024
Q1 		$19.9K Hold
145
– – ﹤0.01% 585
2023
Q4 		$19.7K Hold
145
– – ﹤0.01% 577
2023
Q3 		$17.6K Hold
145
– – ﹤0.01% 612
2023
Q2 		$18.6K Hold
145
– – ﹤0.01% 597
2023
Q1 		$18.7K Hold
145
– – ﹤0.01% 591
2022
Q4 		$19K Hold
145
– – ﹤0.01% 590
2022
Q3 		$17K Hold
145
– – ﹤0.01% 595
2022
Q2 		$17K Hold
145
– – ﹤0.01% 600
2022
Q1 		$19K Buy
+145
New +$18.9K ﹤0.01% 618

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GHP Investment Advisors's IBB Position: Q4 2024 in Review

GHP Investment Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 46 shares — an estimated $6.7K sold.

GHP Investment Advisors first reported a position in IBB in Q1 2022 and held it in 10 quarters. The position peaked at $19.9K in Q1 2024. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • GHP Investment Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • GHP Investment Advisors sold 46 iShares Biotechnology ETF shares in Q4 2024, an estimated $6.7K.
  • GHP Investment Advisors first reported a position in iShares Biotechnology ETF in Q1 2022 and held it in 10 quarters.
  • GHP Investment Advisors's iShares Biotechnology ETF position peaked at $19.9K in Q1 2024.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on GHP Investment Advisors's 13F filing for Q4 2024, filed 27 Jan 2025.